IBCSG 19-01 MA.17

  • Phase III randomised double blind study of Letrozole versus placebo in women with primary breast cancer completing five or more years of adjuvant Tamoxifen

  • Study Chair
    Prof. Monica Castiglione - Bern, Switzerland

    Trial Coordinator
    Rita Pfister


    ETOP IBCSG Partners Foundation
    Coordinating Center, Bern, Switzerland
    Phone: +41 31 511 94 00
    Fax: +41 31 511 94 01
    Email: This email address is being protected from spambots. You need JavaScript enabled to view it.

     

    Date of Activation
    September 3, 2001

    Date of Closure
    May 31, 2002

    Targeted Accrual
    4800 patients

    Final Accrual
    5031 patients

ETOP IBCSG Partners Foundation
Effingerstrasse 33
3008 Bern, Switzerland

Contact
Phone: +41 31 511 94 00
E-mail: contact@etop.ibcsg.org

Member Login